Red cell distribution width in adults with congenital heart disease: A worldwide available and low-cost predictor of cardiovascular events

RDW is associated with cardiovascular events in patients with ACHD, independently of age, sex, clinical risk factors, CRP, and NT-proBNP. This readily available biomarker could therefore be considered as an additive biomarker for risk stratification in these patients.